Mark Lance Shibuya

Array ( [id] => 4051942 [patent_doc_number] => 05932557 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Adenosine A.sub.1 receptor antisense oligonucleotide treatment of alcohol and marijuana-induced psychomotor impairments' [patent_app_type] => 1 [patent_app_number] => 8/909868 [patent_app_country] => US [patent_app_date] => 1997-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4424 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932557.pdf [firstpage_image] =>[orig_patent_app_number] => 909868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3991293 [patent_doc_number] => 05985564 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Assay for identifying agents that inhibit chromosome non-disjunction' [patent_app_type] => 1 [patent_app_number] => 8/875972 [patent_app_country] => US [patent_app_date] => 1997-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 29 [patent_no_of_words] => 16168 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985564.pdf [firstpage_image] =>[orig_patent_app_number] => 875972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946061 [patent_doc_number] => 05998383 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Antitumor antisense sequences directed against ribonucleotide reductase' [patent_app_type] => 1 [patent_app_number] => 8/904901 [patent_app_country] => US [patent_app_date] => 1997-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 34364 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998383.pdf [firstpage_image] =>[orig_patent_app_number] => 904901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4196479 [patent_doc_number] => 06013488 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Method for reverse transcription' [patent_app_type] => 1 [patent_app_number] => 8/899392 [patent_app_country] => US [patent_app_date] => 1997-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5031 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013488.pdf [firstpage_image] =>[orig_patent_app_number] => 899392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4189795 [patent_doc_number] => 06130038 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-10 [patent_title] => 'Method for amplifying target nucleic acids using modified primers' [patent_app_type] => 1 [patent_app_number] => 8/893300 [patent_app_country] => US [patent_app_date] => 1997-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21514 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/130/06130038.pdf [firstpage_image] =>[orig_patent_app_number] => 893300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4102786 [patent_doc_number] => 06066726 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Neuron-specific transcriptional promoter' [patent_app_type] => 1 [patent_app_number] => 8/889502 [patent_app_country] => US [patent_app_date] => 1997-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 28 [patent_no_of_words] => 27049 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066726.pdf [firstpage_image] =>[orig_patent_app_number] => 889502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356288 [patent_doc_number] => 06190909 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'TH2-specific gene' [patent_app_type] => 1 [patent_app_number] => 8/884077 [patent_app_country] => US [patent_app_date] => 1997-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 3 [patent_no_of_words] => 33742 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/190/06190909.pdf [firstpage_image] =>[orig_patent_app_number] => 884077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946948 [patent_doc_number] => 05955279 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Ataxia-telangiectasia: mutations in the ATM gene' [patent_app_type] => 1 [patent_app_number] => 8/874266 [patent_app_country] => US [patent_app_date] => 1997-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 11 [patent_no_of_words] => 20363 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 276 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955279.pdf [firstpage_image] =>[orig_patent_app_number] => 874266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4179695 [patent_doc_number] => 06020142 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders' [patent_app_type] => 1 [patent_app_number] => 8/870815 [patent_app_country] => US [patent_app_date] => 1997-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 35587 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020142.pdf [firstpage_image] =>[orig_patent_app_number] => 870815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1436146 [patent_doc_number] => 06355790 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Inhibition of HIV replication using a mutated transfer RNA primer' [patent_app_type] => B1 [patent_app_number] => 08/866116 [patent_app_country] => US [patent_app_date] => 1997-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 14782 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355790.pdf [firstpage_image] =>[orig_patent_app_number] => 08866116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3931091 [patent_doc_number] => 05928869 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Detection of nucleic acids by fluorescence quenching' [patent_app_type] => 1 [patent_app_number] => 8/865675 [patent_app_country] => US [patent_app_date] => 1997-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10817 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/928/05928869.pdf [firstpage_image] =>[orig_patent_app_number] => 865675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3834546 [patent_doc_number] => 05846726 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Detection of nucleic acids by fluorescence quenching' [patent_app_type] => 1 [patent_app_number] => 8/855085 [patent_app_country] => US [patent_app_date] => 1997-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8641 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846726.pdf [firstpage_image] =>[orig_patent_app_number] => 855085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3910168 [patent_doc_number] => 06001654 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-.beta. super family growth factors' [patent_app_type] => 1 [patent_app_number] => 8/846028 [patent_app_country] => US [patent_app_date] => 1997-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 25 [patent_no_of_words] => 21317 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001654.pdf [firstpage_image] =>[orig_patent_app_number] => 846028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565274 [patent_doc_number] => 06339066 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-15 [patent_title] => 'Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate I, II, , , , and isoforms of human protein kinase C' [patent_app_type] => B1 [patent_app_number] => 08/829637 [patent_app_country] => US [patent_app_date] => 1997-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 26702 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/339/06339066.pdf [firstpage_image] =>[orig_patent_app_number] => 08829637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190248 [patent_doc_number] => 06130063 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-10 [patent_title] => 'DNA sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi' [patent_app_type] => 1 [patent_app_number] => 8/828152 [patent_app_country] => US [patent_app_date] => 1997-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 10819 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/130/06130063.pdf [firstpage_image] =>[orig_patent_app_number] => 828152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3939304 [patent_doc_number] => 05872106 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Antimessenger oligonucleotide against urokinase receptor' [patent_app_type] => 1 [patent_app_number] => 8/776062 [patent_app_country] => US [patent_app_date] => 1997-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2544 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/872/05872106.pdf [firstpage_image] =>[orig_patent_app_number] => 776062 [rel_patent_id] =>[rel_patent_doc_number] =>)